EDITAS MEDICINE, INC. Financing Cash Flow
EDITAS MEDICINE, INC. (EDIT) reported Financing Cash Flow of $117.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-05
- EDITAS MEDICINE, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $117.53M, a 1485.74% increase year-over-year.
- EDITAS MEDICINE, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was $0.00.
- EDITAS MEDICINE, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was $17.33M, a 68.79% decline year-over-year.
- EDITAS MEDICINE, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $17.17M.
- EDITAS MEDICINE, INC. net cash provided by (used in) financing activities for fiscal 2025 was $40.47M, a 27.77% decline from fiscal 2024.
- EDITAS MEDICINE, INC. net cash provided by (used in) financing activities for fiscal 2024 was $56.03M, a 52.54% decline from fiscal 2023.
- EDITAS MEDICINE, INC. net cash provided by (used in) financing activities for fiscal 2023 was $118.04M, a 9093.07% increase from fiscal 2022.
- EDITAS MEDICINE, INC. net cash provided by (used in) financing activities for fiscal 2022 was $1.28M, a 99.54% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $117.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $117.53M 10-Q · filed 2026-08-05 | $134.86M derived: sum of 3 quarters · filed 2026-08-05 | $152.03M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-05 | $17.33M derived: sum of 2 quarters · filed 2026-05-05 | $34.49M derived: sum of 3 quarters · filed 2026-05-05 | $41.91M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $17.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $34.49M derived: sum of 2 quarters · filed 2026-03-09 | $41.91M derived: sum of 3 quarters · filed 2026-08-05 | $40.47M 10-K · filed 2026-03-09 |
| 2025-09-30 | $17.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $24.58M derived: sum of 2 quarters · filed 2026-08-05 | $23.14M 10-Q · filed 2025-11-10 | $78.66M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $7.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $5.97M 10-Q · filed 2026-08-05 | $61.49M derived: sum of 3 quarters · filed 2026-08-05 | $61.49M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | -$1.44M 10-Q · filed 2026-05-05 | $54.08M derived: sum of 2 quarters · filed 2026-05-05 | $54.08M derived: sum of 3 quarters · filed 2026-05-05 | $54.40M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $55.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $55.51M derived: sum of 2 quarters · filed 2026-03-09 | $55.84M derived: sum of 3 quarters · filed 2026-03-09 | $56.03M 10-K · filed 2026-03-09 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $322.00K derived: sum of 2 quarters · filed 2025-11-10 | $514.00K 10-Q · filed 2025-11-10 | $1.03M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $322.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $514.00K 10-Q · filed 2025-08-12 | $1.03M derived: sum of 3 quarters · filed 2025-08-12 | $1.03M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $192.00K 10-Q · filed 2025-05-12 | $706.00K derived: sum of 2 quarters · filed 2025-05-12 | $706.00K derived: sum of 3 quarters · filed 2025-05-12 | $118.23M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $514.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $514.00K derived: sum of 2 quarters · filed 2025-03-05 | $118.04M derived: sum of 3 quarters · filed 2025-03-05 | $118.04M 10-K · filed 2025-03-05 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $117.53M derived: sum of 2 quarters · filed 2024-11-04 | $117.53M 10-Q · filed 2024-11-04 | $118.14M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-06-30 | $117.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | $117.53M 10-Q · filed 2024-08-07 | $118.14M derived: sum of 3 quarters · filed 2025-03-05 | $118.22M derived: sum of 4 quarters · filed 2025-03-05 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $619.00K derived: sum of 2 quarters · filed 2025-03-05 | $699.00K derived: sum of 3 quarters · filed 2025-03-05 | $1.07M derived: sum of 4 quarters · filed 2025-03-05 |
| 2022-12-31 | $619.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-05 | $699.00K derived: sum of 2 quarters · filed 2025-03-05 | $1.07M derived: sum of 3 quarters · filed 2025-03-05 | $1.28M 10-K · filed 2025-03-05 |
| 2022-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $447.00K derived: sum of 2 quarters · filed 2023-11-03 | $665.00K 10-Q · filed 2023-11-03 | $1.72M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $367.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $585.00K 10-Q · filed 2023-08-02 | $1.64M derived: sum of 3 quarters · filed 2024-02-28 | $4.14M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $218.00K 10-Q · filed 2023-05-05 | $1.27M derived: sum of 2 quarters · filed 2024-02-28 | $3.77M derived: sum of 3 quarters · filed 2024-02-28 | $20.85M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.06M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.55M derived: sum of 2 quarters · filed 2024-02-28 | $20.64M derived: sum of 3 quarters · filed 2024-02-28 | $282.11M 10-K · filed 2024-02-28 |
| 2021-09-30 | $2.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | $19.58M derived: sum of 2 quarters · filed 2022-11-02 | $281.05M 10-Q · filed 2022-11-02 | $290.15M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $17.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $278.55M 10-Q · filed 2022-08-03 | $287.65M derived: sum of 3 quarters · filed 2023-02-22 | $288.48M derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $261.47M 10-Q · filed 2022-05-04 | $270.57M derived: sum of 2 quarters · filed 2023-02-22 | $271.39M derived: sum of 3 quarters · filed 2023-02-22 | $482.55M derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $9.10M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $9.92M derived: sum of 2 quarters · filed 2023-02-22 | $221.07M derived: sum of 3 quarters · filed 2023-02-22 | $224.12M 10-K · filed 2023-02-22 |
| 2020-09-30 | $822.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $211.97M derived: sum of 2 quarters · filed 2021-11-09 | $215.02M 10-Q · filed 2021-11-09 | $299.59M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $211.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $214.20M 10-Q · filed 2021-08-05 | $298.77M derived: sum of 3 quarters · filed 2022-02-24 | $342.12M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $3.05M 10-Q · filed 2021-05-06 | $87.62M derived: sum of 2 quarters · filed 2022-02-24 | $130.97M derived: sum of 3 quarters · filed 2022-02-24 | $133.34M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $84.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $127.92M derived: sum of 2 quarters · filed 2022-02-24 | $130.29M derived: sum of 3 quarters · filed 2022-02-24 | $131.82M 10-K · filed 2022-02-24 |
| 2019-09-30 | $43.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $45.72M derived: sum of 2 quarters · filed 2020-11-06 | $47.26M 10-Q · filed 2020-11-06 | $77.61M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-06-30 | $2.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $3.90M 10-Q · filed 2020-08-07 | $34.25M derived: sum of 3 quarters · filed 2021-02-26 | $35.49M derived: sum of 4 quarters · filed 2021-02-26 |
| 2019-03-31 | $1.53M 10-Q · filed 2020-05-08 | $31.89M derived: sum of 2 quarters · filed 2021-02-26 | $33.13M derived: sum of 3 quarters · filed 2021-02-26 | $35.79M derived: sum of 4 quarters · filed 2021-02-26 |
| 2018-12-31 | $30.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $31.59M derived: sum of 2 quarters · filed 2021-02-26 | $34.26M derived: sum of 3 quarters · filed 2021-02-26 | $86.94M 10-K · filed 2021-02-26 |
| 2018-09-30 | $1.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | $3.91M derived: sum of 2 quarters · filed 2019-11-12 | $56.59M 10-Q · filed 2019-11-12 | $115.07M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-06-30 | $2.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $55.35M 10-Q · filed 2019-08-07 | $113.83M derived: sum of 3 quarters · filed 2020-02-26 | $113.10M derived: sum of 4 quarters · filed 2020-02-26 |
| 2018-03-31 | $52.68M 10-Q · filed 2019-05-08 | $111.16M derived: sum of 2 quarters · filed 2020-02-26 | $110.43M derived: sum of 3 quarters · filed 2020-02-26 | $110.12M derived: sum of 4 quarters · filed 2020-02-26 |
| 2017-12-31 | $58.48M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-26 | $57.75M derived: sum of 2 quarters · filed 2020-02-26 | $57.44M derived: sum of 3 quarters · filed 2020-02-26 | $154.53M 10-K · filed 2020-02-26 |
| 2017-09-30 | -$730.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | -$1.04M derived: sum of 2 quarters · filed 2018-11-08 | $96.06M 10-Q · filed 2018-11-08 | $95.52M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | -$309.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $96.78M 10-Q · filed 2018-08-07 | $96.25M derived: sum of 3 quarters · filed 2019-03-01 | $96.22M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $97.09M 10-Q · filed 2018-05-04 | $96.56M derived: sum of 2 quarters · filed 2019-03-01 | $96.53M derived: sum of 3 quarters · filed 2019-03-01 | |
| 2016-12-31 | -$538.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$560.00K derived: sum of 2 quarters · filed 2019-03-01 | $97.16M 10-K · filed 2019-03-01 | |
| 2016-09-30 | -$22.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $97.70M 10-Q · filed 2017-11-08 | ||
| 2016-06-30 | $97.72M 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | $139.39M 10-K · filed 2018-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |